Clinical Trials Browser

Phase 3 × Recruiting × icotinib × Clear all

NCT06041776 2023-09-22

Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung